To evaluate global sensory impairment (GSI, an integrated measure of sensory dysfunction) as a predictor of physical function, cognition, overall health, and mortality. DESIGN: Prospective study. SETTING: The National Social Life, Health, and Aging Project. PARTICIPANTS: A national probability sample of 3,005 home-dwelling older U.S. adults assessed at baseline and 5-year follow-up (2010-11). MEASUREMENTS: Gait speed, activity, disability, cognition, overall health, 5-year mortality. RESULTS: At baseline, older adults with worse GSI were slower (Timed Up and Go times: odds ratio (OR) = 1.32, 95% confidence interval (CI) = 1.17-1.50) and had more activity of daily living deficits (≥2: OR = 1.26, 95% CI = 1.10-1.46). Five years later, they were still slower (timed walk: OR = 1.22, 95% CI = 1.05-1.42), had more disabilities (≥2 instrumental activities of daily living; OR = 1.45, 95% CI = 1.23-1.70), were less active (daytime activity according to accelerometry: b = À2.7, 95% CI = À5.2 to À0.2), had worse cognitive function (Montreal Cognitive Assessment; b = À0.64, 95% CI = À0.84 to À0.44), more likely to have poorer overall health (OR = 1.16, 95% CI = 1.03-1.31) and lose weight (>10%: OR = 1.31, 95% CI = 1.04-1.64), and have died (OR = 1.45, 95% CI = 1.19-1.76). All analyses were adjusted for relevant confounders at baseline, including age, sex, race and ethnicity, education, smoking, problem drinking, body mass index, comorbidities, and cognitive function. CONCLUSION: GSI predicts impaired physical function, cognitive dysfunction, significant weight loss, and mortality 5 years later in older U.S. adults. Multisensory evaluation may identify vulnerable individuals, offering the opportunity for early intervention to mitigate adverse outcomes.
S
ensory loss commonly affects how older adults live and interact with their environments and other people and plays a critical role in disease, often with profound consequences. Sensory loss is associated with an array of detrimental clinical and functional outcomes, depending on the sense involved. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Evidence supporting such relationships has focused primarily on single-sensory modalities or dual impairments (typically vision and hearing), and dual deficits have ben found to have synergistic detrimental effects. [12] [13] [14] Multisensory loss appears to be common in older U.S. adults 15, 16 but has been little studied. There are specific neurophysiological changes associated with aging that could increase dysfunction in all senses. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] To the knowledge of the authors of the current study, concurrent sensory deficits in all classical senses (vision, hearing, taste, smell, touch) have not been reported.
To address this gap, the concept of global sensory impairment (GSI), which captures common mechanisms underlying decline of the classical senses, was proposed and tested. 16 This model showed that a common underlying factor explained a significant amount of variation in each of the sensory dysfunctions, supporting the concept of a unified underlying process of sensory aging. Such a framework is conceptually similar to the common cause hypothesis in aging, wherein a common factor is responsible for age-related deterioration in cognitive and noncognitive processes. 6, 27 In contrast, GSI is limited in focus to the senses by definition, which is different from studies modeling aging across a wide array of physiological systems. 28 Nevertheless, multiple sensory deficits, similar to multiple physical impairments, 29 constitute an important facet of the aging process that may provide complementary information. This idea remains to be tested rigorously.
The current prospective study was designed to determine whether and how GSI predicts important health outcomes in the National Social Life, Health, and Aging Project (NSHAP). 30 
METHODS

Respondents and Study Design
In 2005-06, interviewers conducted baseline in-home interviews with 3,005 home-dwelling older adults identified using a national probability sample of the population of home-dwelling adults aged 57-85. 30 Sensory function of all five classical senses was assessed. 31, 32 Five years later (2010-11), respondents who remained alive were interviewed again. 33 Information collected at baseline included measures of mobility, disability, demographic characteristics, health behaviors, body mass index (BMI), comorbid diseases, and cognitive function. 34, 35 Five years later, several measures were improved (notably cognition and activity, as detailed below); because of other changes in the study, some measures could not be included (notably measurement of all five senses) (Data S1).
Function of Five Classical Senses in the Home
Methods for measuring the five classical senses at baseline 16, 32 have been described (Data S2).
GSI Score
The GSI score measures the underlying processes common to dysfunction of all five classic senses and is derived from a generalized single-factor measurement model that was fit to the five observed sensory dysfunction measures 16 (Data S2).
Baseline Measures of Physical Function
Mobility was measured at baseline in a random subset of participants (Table 1) using the Timed Up and Go Test  (TUG) . 36 TUG times were categorized as normal (≤10 seconds), delayed (11-20 seconds), or impaired (>20 seconds or wheelchair bound).
Disability was measured according to respondent report of difficulty performing seven activities of daily living (ADLs) ( Table 1) . 37 The ADL disability variable was collapsed into two categories: difficulty with two or more ADLs versus difficulty with fewer than two ADLs.
Baseline Covariates
Demographic traits
Race and Hispanic ethnicity were classified using standard National Institutes of Health terms. Education was categorized according to the highest degree or certification earned. Health behaviors (problem drinking, current tobacco use) were assessed as previously described. 38 Body mass index (BMI) was calculated from measured height and weight and categorized using standard thresholds. Health was measured using a Charlson Comorbidity Index modified for survey use (Modified Comorbidity Index, range 0-24). 39 Diabetes mellitus and hypertension were included separately because of specific interest in the effect of these diseases. Cognitive function was assessed using a version of the Short Portable Mental Status Questionnaire (SPMSQ) modified for survey use (range 0-10). 40 
Five-Year Outcome Measures
Impaired Mobility
At 5-year follow-up, mobility was measured in all returning participants using a 3-m timed walk (TW) ( Table 1 ). The fastest performance on two attempts was categorized for increasing impairment as excellent (≤3.1 seconds), good (3.2-4 seconds), fair (4.1-5.6 seconds), or poor (≥5.7 seconds or unable to complete the task). 37 Adjusting for height and weight separately, instead of BMI, did not change the reported findings.
Disability
At 5-year follow-up, all returning respondents (Table 1) reported degree of difficulty completing eight instrumental activities of daily living (IADLs). 37 The IADL disability variable was collapsed into two categories: difficulty with two or more IADLs versus difficulty with fewer than two IADLs.
Physical Activity
Mean daytime activity count was calculated during the awake interval using standard criteria using data from a wrist-worn accelerometer (Actiwatch Spectrum, Philips Respironics, Eindhoven, the Netherlands) in an accelerometry substudy (Table 1) . 37 Higher values indicate greater activity.
Cognition
Cognition was measured (Table 1) using the Montreal Cognitive Assessment adapted for survey administration (MoCA-SA, previously termed the Chicago Cognitive Function Measure). 41, 42 Higher values indicate better function.
Health
Respondents rated their overall physical and mental health on a 5-point scale from excellent to poor (Table 1) . Weight loss of at least 10% between baseline and followup was calculated directly. The effect of cancer on weight loss was directly controlled for by removing cancer diagnosis from the baseline modified comorbidity index and adding it independently to the prospective analyses of weight loss.
Mortality
Vitality was confirmed using validated methods 43 (Data S3).
Statistical Analysis
Different types of analyses were used to test the associations between GSI and other variables based on their measurement type: ordinal or standard logistic regressions for ordinal (TUG, TW, self-reported physical and mental health) and binary (≥2 ADLs or IADLs, >10% weight loss, mortality) data and linear regression for continuous data (mean daytime activity count and MoCA-SA score). Effect sizes reported for these relationships (odds ratios (ORs), linear regression coefficients) are presented in terms of a 1-standard deviation (SD) increase in GSI. Baseline covariates common to all models included age, sex, race, education, smoking, problem drinking, BMI, modified comorbidity index, diabetes mellitus, hypertension and cognition. For analyses examining 5-year outcomes at follow-up, to assess the predictive power of GSI in addition to the baseline condition of the variable being analyzed, the baseline measures of the predicted variable were also included. Estimate based on wrist accelerometry data and calculated as sum of activity counts divided by the total number of 15-second epochs during the awake interval for each individual. Roughly one-third of Wave 2 respondents (n = 793) were randomly assigned to the accelerometry substudy by design, and n = 522 of these substudy participants had global sensory impairment data. SD = standard deviation.
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Analyses were weighted to account for differing probabilities of nonresponse and selection 33, 44 and therefore describe the population of older U.S. adults living in their homes. Design-based standard errors were calculated using the linearization method together with the strata and primary sampling unit indicators provided with the data set. Analyses were performed using Stata version 14 (StataCorp LP, College Station, TX).
RESULTS
Associations with Physical Function at Baseline
Mobility
Greater GSI was associated with markedly worse mobility on the TUG (OR = 1.32 per 1-SD increase in GSI, 95% CI = 1.17-1.50, P < .001; Table 2 ), adjusting for age, sex, race, education, tobacco use, problem drinking, BMI, comorbidity, and cognitive function. As expected, older respondents, women, and those with greater comorbidity (specifically diabetes mellitus) had slower TUG times.
Disability
Individuals with greater GSI were more likely to have two or more difficulties with ADLs, adjusting for the same covariates as above (OR = 1.26, 95% CI = 1.10-1.46, P = .002; Table 2 ). Women, older respondents, smokers, and those with greater comorbidity all had greater disability.
Mobility and disability were therefore added as baseline covariates in the prospective analysis of GSI as predictors of daytime physical activity 5 years later.
5-Year Outcomes
Impaired Mobility
Greater GSI at baseline was associated with slower walking 5 years later (TW: OR = 1.22, 95% CI = 1.05-1.42, P = .01; Figure 1 , Table S1 ) after adjusting for all the baseline covariates and baseline TUG performance, indicating the predictive power of GSI even when adjusting for baseline impaired mobility. Participants who were older, women, minorities, and those with less education walked significantly more slowly than those who had obesity, hypertension, and more comorbidities at baseline.
Disability
Participants with greater GSI at baseline had greater odds of having difficulty with 2 or more IADLs 5 years later (OR = 1.45, 95% CI = 1.23-1.70, P < .001; Figure 1 , Table S1 ) after controlling for ADL disability at baseline and other baseline covariates, also indicating the predictive power of GSI even when adjusting for level of baseline disabilities. In addition, participants who were older, women, and those with less education had significantly more disabilities than those who were smokers and had more comorbidities and poorer cognitive status at baseline.
Physical Activity
Participants with greater GSI at baseline had less daytime activity (accelerometry) 5 years later (b = À2.7, 95% CI = À5.2 to À0.2, P = .03; Table 3 ), similarly adjusted for baseline covariates, including baseline impaired mobility and disabilities. Less-active respondents were also more likely to be older and male, although men walked more quickly and had fewer disabilities, as is common at older ages. Participants who were less active were more likely to have been smokers at baseline and to have an abnormal BMI (underweight, overweight, or obese), hypertension or diabetes mellitus, and better baseline cognition.
Cognitive Function
Worse GSI at baseline also predicted poorer cognition 5 years later (b = À0.64, 95% CI = À0.84 to À0.44, P < .001; Table 3 ), adjusted for the same baseline demographic and health covariates, including baseline cognition, indicating the predictive power of GSI over baseline cognitive abilities. Those with worse cognition at follow-up were more likely to be male, minorities, less educated, underweight, and hypertensive.
Overall Health Outcomes
High baseline GSI was also associated with worse selfreported physical (OR = 1.16, 95% CI = 1.03-1.31, P = .02; Table S2 ) and mental (OR = 1.12, 95% CI = 0.99-1.26, P = .06; Table S2 ) health 5 years later, independent of baseline physical and mental health and the standard baseline covariates. Participants who reported poor physical and mental health at follow-up included participants were less educated, smoked, and were under-or overweight at baseline. Those who had more baseline comorbidities, particularly diabetes mellitus and hypertension, subsequently reported poorer physical health, whereas those with poor baseline cognition reported poorer mental health. Worse GSI was also associated with greater odds of a 10% or more decline in weight 5 years later, adjusted for baseline covariates and interim development of cancer (OR = 1.31, 95% CI = 1.04-1.64, P = .02; Figure 1 , Table S3 ). Older respondents, women, African Americans, smokers, problem drinkers, and those who were overweight or obese or did not have hypertension were also more likely to lose a significant amount of weight (>10% from baseline).
GSI and 5-Year Mortality
Greater GSI was associated with greater odds of death (OR = 1.45, 95% CI = 1.19-1.76, P < .001; Table S3) in a model that adjusted for all baseline covariates, as well as baseline impaired mobility, an important component of frailty. Older and less-educated respondents had greater odds of death, as did those who were smokers or underweight and had greater comorbidity (particularly diabetes mellitus) and worse cognition at baseline (Figure 1 , Table S3 ). Dysfunction in any one sense did not determine these results (Table S4) ; GSI effectively captured the Figure 1 . Global sensory impairment predicts worse mobility and function, weight loss, and greater mortality 5 years later (mean probability, adjusting for baseline covariates; see Tables S1 and S3 for full models). The probability of taking more than 4 seconds on the timed walk increases from 0.48 for those with the lowest GSI score to 0.68 for those with the highest. The probability of having two or more instrumental activity of daily living difficulties increases from 0.16 for those with the lowest GSI score to 0.47 for those with the highest, and the probability of having more than 10% weight loss increases from 0.08 to 0.25. The probability of 5-year mortality increases from 0.07 for those with the lowest GSI score to 0.27 for those with the highest. The gray shaded areas represent 95% confidence bounds for the estimates. association between the individual sensory dysfunctions and mortality.
Sensitivity Analysis
To test whether these results were robust, a sensitivity analysis was performed that included only respondents with complete data for sensory function (n = 1,301). These results were nearly identical, supporting the conclusions (data not shown).
DISCUSSION
This study shows for the first time that deficits in sensory function in all five senses (GSI) at baseline independently predict major health outcomes assessed 5 years later, including death, strongly supporting the concept that sensory impairment is a critical part of aging. These results suggest that the relationship between sensory dysfunction and poor health is profound. This concept of a common underlying process shared across all five senses contrasts with prior work examining the effect of specific sensory deficits independently (or in subsets of two or three). 6, 15 Instead, GSI measures the intrinsic mechanisms common to deterioration of all the senses, for example, neurophysiological changes associated with aging (e.g., loss of lateral inhibition, decreased specialization of neural pathways and greater connectivity, decrease in white matter density and thinning of the cortex) 45 that are the result of a variety of mechanisms. Thus, decline of the sensory systems would serve as an early harbinger that reflects general neurophysiological decline.
Alternatively, it is possible that decreased sensory input due to peripheral decline causes or accelerates the loss of neuronal connections in the brain, potentially increasing cognitive load 46, 47 and hastening development of neurodegeneration. These two mechanisms (common cause etiology and sequelae of information degradation) are not mutually exclusive. 37, 48 Identifying mechanisms underlying these findings will be important in future work.
Prior work examining the cumulative effects of deficits in one to three senses demonstrated that more deficits interfere to a greater degree with daily living, quality of life, and health outcomes, [49] [50] [51] probably primarily mediated through behaviors. In contrast, the approach of the current study introduces the concept of an intrinsic mechanism common to all senses that also affects other physiological systems and leads to accelerated aging and death. For example, previous work pinpointed olfaction as an important predictor of health and mortality in older adults when considered independently, 15 in contrast to vision and hearing. The current study shows that all five classical senses share the component of olfaction underlying this relationship. GSI predicts many of the components of physical frailty included in three of the major, standard models (e.g., slow gait, weight loss, low activity). [52] [53] [54] This fundamental question of the precise relationship between sensory impairment and physical frailty remains unanswered here, a limitation, calling for additional study to determine whether GSI is an independent phenomenon or shares underlying mechanisms with other physiological processes. Regardless, GSI complements the concept of physical frailty and is an important component of aging.
Future work would benefit from the inclusion of additional clinical measures of sensory function (e.g., near and distance vision, audiometry). The focus of NSHAP was on life at home, in contrast to clinic-or hospital-based assessments, which were not possible. Nevertheless, it is likely that the burden of sensory impairments was underestimated; better precision in the measures would probably make the results more robust. For example, it is likely that the social measure of hearing (measuring conversational ability) overestimates performance relative to standard audiometric measures. Thus, it is likely that these results are conservative. There may be similar imprecision in other sensory measures, but it is unlikely that these would substantially alter the main results. 16 Another limitation is that some measures were not identical at follow-up. Nonetheless, all measures were validated tools and capture useful information, and it is unlikely that they would have significantly altered the main results. This decision to change some measures precluded incidence or change analyses here (weight loss excepted) and limited the focus to the association between GSI at baseline (adjusting for baseline covariates) and health outcomes at 5-year follow-up. The baseline condition of the health outcomes could have been included in the models, and the predictive power of GSI after accounting for baseline status of each particular health outcome could thereby have been demonstrated.
Although it is possible that unmeasured confounders may be responsible in part for the associations observed, the temporal ordering in the analysis excluded the possibility of simultaneity (that the outcomes at follow-up were causing the sensory impairment at baseline). In addition, temporal ordering adds to the clinical relevance of the results, which provide an additional piece of information that a physician may use to identify individuals at higher risk of subsequent poor outcomes. Future studies will be able to use longitudinal data to focus more specifically on the underlying causal processes.
Another limitation is that the SPMSQ (a screening instrument) does not adjust completely for differences in cognitive function at baseline; future follow-up with the same detailed cognitive measures are needed. These results may be viewed as being relevant for individuals without gross cognitive impairment at baseline; models that do not include adjustment for baseline cognition yield essentially the same results (results are conservative). It was decided to include the SPMSQ to more closely match the objective of the analysis, which was to examine the value of sensory impairment for predicting subsequent outcomes conditional on an individual's observed characteristics at baseline, as a translational concept relevant for clinicians. Future studies may be needed to test these issues and those arising for other baseline covariates vigorously. Although connecting sensory impairment and cognitive impairment may not be new, these results are novel in several ways. We extend this concept to the general population of older U.S. adults to other important health outcomes (e.g., mortality) and consider all five sensory modalities.
Clinical Implications
The presence of multiple sensory deficits can be a clinical biomarker identifying older adults at high risk of poor health outcomes. Such individuals should be placed under close surveillance and undergo additional evaluation. Although incidence or change analyses per se were not performed, the results are consistent with the idea that GSI presages a range of severe health problems that might be delayed or even prevented with intervention. Such a focus would allow clinicians to directly address the identified burdens of these deficits, some of which are correctable (e.g., eyeglasses, surgery for cataracts or refraction, hearing aids or cochlear implants, olfactory training) and may be synergistic 55 and should be considered for implementation. Because insurance does not cover many sensory interventions (e.g., glasses or hearing aids by Medicare), these findings justify health policy changes. Finally, prospective studies of interventions are warranted to understand how sensory function affects and is related to aging, neurodegeneration, and mortality.
Further examination of sensory function of all five senses will provide vital answers to these and other major questions and allow preventive measures to be designed or therapeutic targets identified to mitigate or prevent the burden of GSI for older adults. Moreover, it may allow atrisk individuals to be targeted early (e.g., to prevent cognitive impairment). Such efforts will have a large public health effect.
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